Allurion to Report First Quarter 2025 Financial Results on May 14, 2025. NATICK, Mass., May 05, 2025--Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ...

Allurion to Report First Quarter 2025 Financial Results on May 14, 2025. NATICK, Mass., May 05, 2025--Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ...

Allurion Technologies Inc has a consensus price target of $6.38 based on the ratings of 4 analysts. The high is $16 issued by Roth MKM on March 21, 2025.The low is $2 issued by TD Cowen on October ...

Allurion (ALUR) stock soared 70% after the company announced it is planning to conduct a clinical study of its gastric balloon weight-loss product in combination with GLP-1 drugs.

Average portfolio weight of all funds dedicated to ALUR is 0.04%, an increase of 93.85%. Total shares owned by institutions increased in the last three months by 33.22% to 10,477K shares.

ALUR opened at $3.60 on Monday. The firm has a market capitalization of $17.24 million, a PE ratio of -0.30 and a beta of -0.59. Allurion Technologies has a twelve month low of $2.15 and a twelve ...

Allurion Technologies Inc. (NYSE:ALUR – Free Report) – Research analysts at Roth Capital cut their Q1 2025 earnings per share (EPS) estimates for Allurion Technologies in a report released on ...